Silencing ephrinB3 improves functional recovery following spinal cord injury

Qu,Yang; Zhao,Jianwu; Wang,Yang; Gao,Zhongli

doi:10.3892/mmr.2014.2019

Silencing ephrinB3 improves functional recovery following spinal cord injury

Authors:
- Yang Qu
- Jianwu Zhao
- Yang Wang
- Zhongli Gao
View Affiliations

Affiliations: Department of Orthopaedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin 13033, P.R. China
Published online on: March 6, 2014 https://doi.org/10.3892/mmr.2014.2019
Pages: 1761-1766

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

EphrinB3 may restrict axonal regeneration and recovery following traumatic injury of the adult mammalian central nervous system (CNS). Therefore, inhibition of ephrinB3 expression may enhance the ability of the nervous system to regenerate following damage. In the present study, lentiviral expressing vectors, pGCSIL-GFP, expressing an active small interfering RNA (siRNA) targeting the EphB3 sequence, were used to determine the effect of inhibiting EphB3 on nerve functional recovery and regeneration. Basso-Beattie-Bresnahan (BBB) locomotor scores and growth-associated protein, 43 kDa (GAP43) expression levels were determined at 1, 2, 4 and 8 weeks following transplantation of the siRNA. It was identified that EphB3 mRNA and protein levels in the siRNA group were significantly reduced (P<0.01) in the spine compared with the control group, at four weeks following intraparenchymal administration of the siRNA into the right lumbar. BBB locomotor scores were significantly increased (P<0.05) in siRNA animals compared with the sham group, at 1, 2, 4 and 8 weeks following transplantation of the siRNA. In addition, a significant increase in GAP43 expression was detected in the siRNA group compared with the control group. This preclinical study demonstrates that ephrinB3 silencing contributes to axonal growth regeneration and improves recovery from spinal cord injury (SCI).

View Figures

View References

1	Kose EA, Bakar B, Ayva SK, Kilinc K and Apan A: Neuroprotective effects of racemic ketamine and (S)-ketamine on spinal cord injury in rat. Injury. 43:1124–1130. 2012. View Article : Google Scholar : PubMed/NCBI
2	Bulsara KR, Iskandar BJ, Villavicencio AT and Skene JH: A new millenium for spinal cord regeneration: growth-associated genes. Spine (Phila Pa 1976). 27:1946–1949. 2002. View Article : Google Scholar : PubMed/NCBI
3	Szpara ML, Vranizan K, Tai YC, Goodman CS, Speed TP and Ngai J: Analysis of gene expression during neurite outgrowth and regeneration. BMC Neurosci. 8:1002007. View Article : Google Scholar
4	Busch SA and Silver J: The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol. 17:120–127. 2007. View Article : Google Scholar : PubMed/NCBI
5	Liu BP, Cafferty WB, Budel SO and Strittmatter SM: Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci. 361:1593–1610. 2006. View Article : Google Scholar : PubMed/NCBI
6	McGee AW and Strittmatter SM: The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci. 26:193–198. 2003. View Article : Google Scholar : PubMed/NCBI
7	McKerracher L, David S, Jackson DL, et al: David S, Jackson DL, Kottis V, Dunn RJ and Braun PE: Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13:805–811. 1994. View Article : Google Scholar : PubMed/NCBI
8	Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR and Filbin MT: A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13:757–767. 1994. View Article : Google Scholar
9	Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F and Schwab ME: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:434–439. 2000. View Article : Google Scholar : PubMed/NCBI
10	GrandPré T, Nakamura F, Vartanian T and Strittmatter SM: Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:439–444. 2000.PubMed/NCBI
11	Hata K, Hata K, Fujitani M, Yasuda Y, Doya H, Saito T, Yamagishi S, Mueller BK and Yamashita T: RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J Cell Biol. 173:47–58. 2006. View Article : Google Scholar : PubMed/NCBI
12	Moreau-Fauvarque C, Kumanogoh A, Camand E, Jaillard C, Barbin G, Boquet I, Love C, Jones EY, Kikutani H, Lubetzki C, Dusart I and Chédotal A: The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci. 23:9229–9239. 2003.PubMed/NCBI
13	Löw K, Culbertson M, Bradke F, Tessier-Lavigne M and Tuszynski MH: Netrin-1 is a novel myelin-associated inhibitor to axon growth. J Neurosci. 28:1099–1108. 2008.PubMed/NCBI
14	Irizarry-Ramírez M, Willson CA, Cruz-Orengo L, Figueroa J, et al: Upregulation of EphA3 receptor after spinal cord injury. J Neurotrauma. 22:929–935. 2005.PubMed/NCBI
15	Klein R: Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat Neurosci. 12:15–20. 2009. View Article : Google Scholar : PubMed/NCBI
16	Aoto J and Chen L: Bidirectional ephrin/Eph signaling in synaptic functions. Brain Res. 1184:72–80. 2007. View Article : Google Scholar : PubMed/NCBI
17	Kullander K, Croll SD, Zimmer M, Pan L, McClain J, Hughes V, Zabski S, DeChiara TM, Klein R, Yancopoulos GD and Gale W: Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control. Genes Dev. 15:877–888
18	Asante CO, Chu A, Fisher M, Benson L, Beg A, Scheiffele P and Martin J: Cortical control of adaptive locomotion in wild-type mice and mutant mice lacking the ephrin-Eph effector protein alpha2-chimaerin. J Neurophysiol. 104:3189–3202. 2010. View Article : Google Scholar : PubMed/NCBI
19	Liu X, Hawkes E, Ishimaru T, Tran T and Sretavan DW: EphB3: an endogenous mediator of adult axonal plasticity and regrowth after CNS injury. J Neurosci. 26:3087–3101. 2006. View Article : Google Scholar : PubMed/NCBI
20	Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, Scherz P, Skarnes WC and Tessier-Lavigne M: Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature. 410:174–179. 2001. View Article : Google Scholar : PubMed/NCBI
21	Yokoyama N, Romero MI, Cowan CA, Galvan P, Helmbacher F, Charnay P, Parada LF and Henkemeyer M: Forward signaling mediated by ephrin-B3 prevents contralateral corticospinal axons from recrossing the spinal cord midline. Neuron. 29:85–97. 2001. View Article : Google Scholar : PubMed/NCBI
22	Duffy P, Wang X, Siegel CS, Tu N, Henkemeyer M, Cafferty WB and Strittmatter SM: Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proc Natl Acad Sci USA. 109:5063–5068. 2012. View Article : Google Scholar : PubMed/NCBI
23	Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 26:199–213. 2002. View Article : Google Scholar : PubMed/NCBI
24	Coleman JE, Huentelman MJ, Kasparov S, Metcalfe BL, et al: Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo. Physiol Genomics. 12:221–228. 2002.PubMed/NCBI
25	Déglon N, Tseng JL, Bensadoun JC, Zurn AD, Arsenijevic Y, Pereira de Almeida L, Zufferey R, Trono D and Aebischer P: Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson’s disease. Hum Gene Ther. 11:179–190. 2000.PubMed/NCBI
26	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
27	Goldstein LB: Effects of bilateral and unilateral locus coeruleus lesions on beam-walking recovery after subsequent unilateral sensorimotor cortex suction-ablation in the rat. Restor Neurol Neurosci. 11:55–63. 1997.
28	Silver J and Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci. 5:146–156. 2004. View Article : Google Scholar
29	Genander M and Frisén J: Ephrins and Eph receptors in stem cells and cancer. Curr Opin Cell Biol. 22:611–666. 2010.PubMed/NCBI
30	Carmona MA, Murai KK, Wang L, Roberts AJ and Pasquale EB: Glial ephrin-A3 regulates mhippocampal dendritic spine morphology and glutamate transport. Proc Natl Acad Sci USA. 106:12524–12529. 2009. View Article : Google Scholar : PubMed/NCBI
31	Goldshmit Y, Galea MP, Wise G, Bartlett PF and Turnley AM: Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci. 24:10064–10073. 2004. View Article : Google Scholar : PubMed/NCBI
32	Benson MD, Romero MI, Lush ME, Lu QR, Henkemeyer M and Parada LF: Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci USA. 102:10694–10699. 2005. View Article : Google Scholar : PubMed/NCBI
33	Dorn G, Patel S, Wotherspoon G, et al: siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32:e492002. View Article : Google Scholar : PubMed/NCBI
34	Xia H, Mao Q, Eliason S, Harper SQ, Martins IH, Orr HT, Paulson HL, Yang L, Kotin RM and Davidson BL: RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med. 10:816–820. 2004. View Article : Google Scholar : PubMed/NCBI
35	Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, Yang L, Kotin RM, Paulson HL and Davidson BL: RNA interference improves motor and neuropathological abnormalities in a Huntington’s disease mouse model. Proc Natl Acad Sci USA. 102:5820–5825. 2005.
36	Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC, Wong LF, Bilsland LG, Greensmith L, Kingsman SM, Mitrophanous KA, Mazarakis ND and Azzouz M: Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med. 11:429–433. 2005. View Article : Google Scholar : PubMed/NCBI
37	Raoul C, Abbas-Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J, Henderson CE and Aebischer P: Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med. 11:423–428. 2005.PubMed/NCBI
38	Adriaansen J, Vervoordeldonk MJ and Tak PP: Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Rheumatology (Oxford). 45:656–668. 2006. View Article : Google Scholar : PubMed/NCBI
39	Manjunath N, Wu H, Subramanya S and Shankar P: Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev. 61:732–745. 2009. View Article : Google Scholar : PubMed/NCBI